pubmed-article:8682134 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8682134 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:8682134 | lifeskim:mentions | umls-concept:C0033325 | lld:lifeskim |
pubmed-article:8682134 | lifeskim:mentions | umls-concept:C0002962 | lld:lifeskim |
pubmed-article:8682134 | lifeskim:mentions | umls-concept:C0025859 | lld:lifeskim |
pubmed-article:8682134 | lifeskim:mentions | umls-concept:C0042523 | lld:lifeskim |
pubmed-article:8682134 | lifeskim:mentions | umls-concept:C0340288 | lld:lifeskim |
pubmed-article:8682134 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:8682134 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:8682134 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:8682134 | pubmed:dateCreated | 1996-8-20 | lld:pubmed |
pubmed-article:8682134 | pubmed:abstractText | To study long-term treatment effects of metoprolol or verapamil on combined cardiovascular end points and psychological variables in patients with stable angina pectoris. | lld:pubmed |
pubmed-article:8682134 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8682134 | pubmed:language | eng | lld:pubmed |
pubmed-article:8682134 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8682134 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8682134 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8682134 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8682134 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8682134 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8682134 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8682134 | pubmed:month | Jan | lld:pubmed |
pubmed-article:8682134 | pubmed:issn | 0195-668X | lld:pubmed |
pubmed-article:8682134 | pubmed:author | pubmed-author:HjemdahlPP | lld:pubmed |
pubmed-article:8682134 | pubmed:author | pubmed-author:ForslundLL | lld:pubmed |
pubmed-article:8682134 | pubmed:author | pubmed-author:HellKK | lld:pubmed |
pubmed-article:8682134 | pubmed:author | pubmed-author:RehnqvistNN | lld:pubmed |
pubmed-article:8682134 | pubmed:author | pubmed-author:BillingEE | lld:pubmed |
pubmed-article:8682134 | pubmed:author | pubmed-author:ErikssonS VSV | lld:pubmed |
pubmed-article:8682134 | pubmed:author | pubmed-author:WallénN HNH | lld:pubmed |
pubmed-article:8682134 | pubmed:author | pubmed-author:NäsmanPP | lld:pubmed |
pubmed-article:8682134 | pubmed:author | pubmed-author:BjörkanderII | lld:pubmed |
pubmed-article:8682134 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8682134 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:8682134 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8682134 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8682134 | pubmed:pagination | 76-81 | lld:pubmed |
pubmed-article:8682134 | pubmed:dateRevised | 2011-8-25 | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:meshHeading | pubmed-meshheading:8682134-... | lld:pubmed |
pubmed-article:8682134 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8682134 | pubmed:articleTitle | Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS) | lld:pubmed |
pubmed-article:8682134 | pubmed:affiliation | Karolinska Institutet, Department of Internal Medicine, Danderyd Hospital, Sweden. | lld:pubmed |
pubmed-article:8682134 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8682134 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:8682134 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:8682134 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8682134 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8682134 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8682134 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8682134 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8682134 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8682134 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8682134 | lld:pubmed |